Amgros 2027 1.1174.a

Summary

The tender concerns framework agreements for medicines supplied by Amgros I/S to hospital pharmacies in Denmark, with possible resale to the Faroe Islands and Greenland. The agreements are non-exclusive and there is no purchase obligation. Bidders can submit offers for one, several or all lots, and awards are made separately for each lot. There are no minimum suitability requirements, but bidders must confirm the mandatory exclusion grounds via ESPD and the winner must provide supporting evidence before award. The contract performance conditions include Danish marketing authorisation, listing in Medicinpriser.dk, and an EU/EEA manufacturing, import or wholesale licence for medicines.